ny-eso-1 olp4
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2008 (NCT00616941)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Cancer/testis antigen 1Immunity, active
Cancer/testis antigen 1 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ny-eso-1 olp4
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01810016 | Phase 1 | Mar 1, 2013 | Cornell University, Ludwig Institute for Cancer Research, University of London, University of Pittsburgh, University of Virginia |
| NCT00616941 | Phase 1 | Aug 1, 2008 | Cornell University, Ludwig Institute for Cancer Research |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cornell University | Academic/Hospital | 2 | 0 | 1 | 2008 |
| Ludwig Institute for Cancer Research | Academic/Hospital | 2 | 2 | 1 | 2008 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Virginia | Academic/Hospital | 1 | 0 | 1 | 2013 |
5 organizations
Page 1 / 1